Antiviral therapy does not improve outcomes of patients with HBV-related decompensated cirrhosis and undetectable DNA.
Han-Ah LeeYoung-Sun LeeYoung-Kul JungJi Hoon KimHyung Joon YimJong Eun YeonYeon Seok SeoJae Seung LeeHye-Won LeeBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnSeung-Up KimPublished in: Journal of gastroenterology and hepatology (2023)
AVT did not attenuate the risk of death nor HCC in patients with HBV-related decompensated cirrhosis and undetectable HBV DNA.